Publications searcher The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points. Fulltext search Alphabetic A-Z Alphabetic Z-A Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer. PMID: 19515553 Journal: EUROPEAN JOURNAL OF CANCER Year: 2009 Reference: Eur J Cancer. 2009 Sep;45(13):2324-32. Epub 2009 Jun 8. Impact factor: 4.475 Publication type: Paper in international publication Authors: Vergote, I, Finkler, N, del Campo, J, Lohr, A, Hunter, J, Matei, D, Kavanagh, J, Vermorken, J B, Meng, L, Jones, M et al. DOI: 10.1016/j.ejca.2009.05.016 Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer. PMID: 19515553 Journal: EUROPEAN JOURNAL OF CANCER Year: 2009 Reference: Eur J Cancer. 2009 Sep;45(13):2324-32. Epub 2009 Jun 8. Impact factor: Publication type: Paper in international publication Authors: Brown, G; del Campo, J; Finkler, N; Hunter, J; Jones, M; Kavanagh, J; Kaye, S; Lohr, A; Matei, D; Meng, L et al. DOI: 10.1016/j.ejca.2009.05.016 Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1. PMID: 19786654 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Dec 1;27(34):5800-7. Epub 2009 Sep 28. Impact factor: 17.157 Publication type: Paper in international publication Authors: Roth, Bruce, Tolcher, Anthony W, Sarantopoulos, John, Patnaik, Amita, Papadopoulos, Kyriakos, Lin, Chia-Chi, Rodon, Jordi, Murphy, Barbara, Kaiser, Brianne, Zhu, Min et al. DOI: 10.1200/JCO.2009.23.6745 Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1. PMID: 19786654 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Dec 1;27(34):5800-7. Epub 2009 Sep 28. Impact factor: Publication type: Paper in international publication Authors: Deng, Hongjie; Friberg, Greg; Gorski, Kevin S; Kaiser, Brianne; Lin, Chia-Chi; McCaffery, Ian; Murphy, Barbara; Papadopoulos, Kyriakos; Patnaik, Amita; Puzanov, Igor et al. DOI: 10.1200/JCO.2009.23.6745 Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors. PMID: 18795291 Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY Year: 2009 Reference: Cancer Chemother Pharmacol. 2009 May;63(6):1065-71. Impact factor: 2.74 Publication type: Paper in international publication Authors: Dancey, Janet E, Chen, Helen, Tolcher, Anthony W, Takimoto, Chris H, O'Rourke, Pat, Mays, Theresa, Lin, Chia-Chi, Calvo, Emiliano, Papadopoulos, Kyriakos P, Patnaik, Amita et al. DOI: 10.1007/s00280-008-0811-x Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors. PMID: 18795291 Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY Year: 2009 Reference: Cancer Chemother Pharmacol. 2009 May;63(6):1065-71. Impact factor: Publication type: Paper in international publication Authors: Calvo, Emiliano; Chen, Helen; Dancey, Janet E; Lin, Chia-Chi; Mays, Theresa; Mita, Alain C; Mita, Monica M; O'Rourke, Pat; Papadopoulos, Kyriakos P; Patnaik, Amita et al. DOI: 10.1007/s00280-008-0811-x Phase II genomics study of ixabepilone as neoadjuvant treatment for breast cancer. PMID: 19075286 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Feb 1;27(4):526-34. Impact factor: 17.157 Publication type: Paper in international publication Authors: Ciruelos, Eva, Egyhazi, Suzanne, Xu, Li-An, Zerba, Kim E, Lee, Hyerim, Clark, Edwin, Galbraith, Susan, Verrill, Mark, Ludwig, Heinz, Makhson, Anatoly et al. DOI: 10.1200/JCO.2007.14.2646 Phase II genomics study of ixabepilone as neoadjuvant treatment for breast cancer. PMID: 19075286 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Feb 1;27(4):526-34. Impact factor: Publication type: Paper in international publication Authors: Baselga, Jose; Ciruelos, Eva; Clark, Edwin; Egyhazi, Suzanne; Galbraith, Susan; Kubista, Ernst; Lee, Hyerim; Llombart-Cussac, Antoni; Ludwig, Heinz; Makhson, Anatoly et al. DOI: 10.1200/JCO.2007.14.2646 Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer. PMID: 19380449 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Jun 1;27(16):2630-7. Impact factor: 17.157 Publication type: Paper in international publication Authors: Semiglazov, Vladimir, van Dam, Peter, Manikhas, Alexey, Bellet, Meritxell, Mayordomo, Jose, Campone, Mario, Kubista, Ernst, Greil, Richard, Bianchi, Giulia, Steinseifer, Jutta et al. DOI: 10.1200/JCO.2008.18.8391 Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer. PMID: 19380449 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Jun 1;27(16):2630-7. Impact factor: Publication type: Paper in international publication Authors: Baselga, Jose; Bellet, Meritxell; Bianchi, Giulia; Campone, Mario; Dixon, J Michael; Gardner, Humphrey; Greil, Richard; Jonat, Walter; Kubista, Ernst; Lane, Heidi A et al. DOI: 10.1200/JCO.2008.18.8391 Phase II randomized study of Plitidepsin (Aplidin), alone or in association with L-carnitine, in patients with unresectable advanced renal cell carcinoma. PMID: 19370171 Journal: Marine Drugs Year: 2009 Reference: Mar Drugs. 2009;7(1):57-70. Impact factor: 1.2 Publication type: Paper in international publication Authors: Rivera, Fernando, Schoffski, Patrick, Guillem, Vincente, Garcia, Margarita, Lopez-Martin, Jose Antonio, Pollard, Patricia, Dumez, Herlinde, del Muro, Xavier Garcia, Paz-Ares, Luis, Cullell, Martin et al. DOI: 10.3390/md7010057 Phase II randomized study of Plitidepsin (Aplidin), alone or in association with L-carnitine, in patients with unresectable advanced renal cell carcinoma. PMID: 19370171 Journal: Marine Drugs Year: 2009 Reference: Mar Drugs. 2009;7(1):57-70. Impact factor: Publication type: Paper in international publication Authors: Cullell, Martin; del Muro, Xavier Garcia; Dumez, Herlinde; Garcia, Margarita; Guillem, Vincente; Lopez-Martin, Jose Antonio; Paz-Ares, Luis; Pollard, Patricia; Rivera, Fernando; Schoffski, Patrick et al. DOI: 10.3390/md7010057 Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer. PMID: 19556318 Journal: ANNALS OF ONCOLOGY Year: 2009 Reference: Ann Oncol. 2009 Nov;20(11):1794-802. Epub 2009 Jun 25. Impact factor: 4.935 Publication type: Paper in international publication Authors: Cikowska-Wozniak, E, Del Campo, J M, Roszak, A, Bidzinski, M, Ciuleanu, T E, Hogberg, T, Wojtukiewicz, M Z, Poveda, A, Boman, K, Westermann, A M et al. DOI: 10.1093/annonc/mdp198 Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer. PMID: 19556318 Journal: ANNALS OF ONCOLOGY Year: 2009 Reference: Ann Oncol. 2009 Nov;20(11):1794-802. Epub 2009 Jun 25. Impact factor: Publication type: Paper in international publication Authors: Alfaro, V; Alonso-Carrion, L; Balana, C; Bidzinski, M; Boman, K; Brugger, W; Casado, A; Cikowska-Wozniak, E; Ciuleanu, T E; Curescu, S et al. DOI: 10.1093/annonc/mdp198 Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma. PMID: 19540072 Journal: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Year: 2009 Reference: Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1430-6. Impact factor: 4.639 Publication type: Paper in international publication Authors: Rivera, Fernando, Galan, Maica, Tabernero, Josep, Cervantes, Andres, Vega-Villegas, M Eugenia, Gallego, Javier, Laquente, Berta, Rodriguez, Edith, Carrato, Alfredo, Escudero, Pilar et al. DOI: 10.1016/j.ijrobp.2008.12.087 Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma. PMID: 19540072 Journal: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Year: 2009 Reference: Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1430-6. Impact factor: Publication type: Paper in international publication Authors: Alonso-Orduna, Vicente; Anton, Antonio; Aranda, Enrique; Cardenal, Adelaida; Carrato, Alfredo; Cervantes, Andres; Escudero, Pilar; Galan, Maica; Gallego, Javier; Giralt, Jordi et al. DOI: 10.1016/j.ijrobp.2008.12.087 Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer. PMID: 19332727 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 May 20;27(15):2474-81. Impact factor: 17.157 Publication type: Paper in international publication Authors: Eiermann, Wolfgang, Gianni, Luca, Baselga, Jose, Lluch, Ana, Zambetti, Milvia, Sabadell, Dolores, Raab, Gunther, Cussac, Antonio Llombart, Bozhok, Alla, Martinez-Agullo, Angel et al. DOI: 10.1200/JCO.2008.19.2567 Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer. PMID: 19332727 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 May 20;27(15):2474-81. Impact factor: Publication type: Paper in international publication Authors: Baselga, Jose; Bonadonna, Gianni; Bozhok, Alla; Byakhov, Mikhail; Cussac, Antonio Llombart; Eiermann, Wolfgang; Gianni, Luca; Greco, Marco; Lluch, Ana; Lopez, Juan Jose Lopez et al. DOI: 10.1200/JCO.2008.19.2567 Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract. PMID: 19687335 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Sep 20;27(27):4454-61. Epub 2009 Aug 17. Impact factor: 17.157 Publication type: Paper in international publication Authors: Bellmunt, Joaquim, Theodore, Christine, Demkov, Tomasz, Komyakov, Boris, Sengelov, Lisa, Daugaard, Gedske, Caty, Armelle, Carles, Joan, Jagiello-Gruszfeld, Agnieszka, Karyakin, Oleg et al. DOI: 10.1200/JCO.2008.20.5534 Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract. PMID: 19687335 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Sep 20;27(27):4454-61. Epub 2009 Aug 17. Impact factor: Publication type: Paper in international publication Authors: Bellmunt, Joaquim; Carles, Joan; Caty, Armelle; Culine, Stephane; Daugaard, Gedske; Delgado, Francois-Michel; Demkov, Tomasz; Hurteloup, Patrick; Jagiello-Gruszfeld, Agnieszka; Karyakin, Oleg et al. DOI: 10.1200/JCO.2008.20.5534 [Phenotypic characterization and course of chronic obstructive pulmonary disease in the PAC-COPD Study: design and methods] PMID: 19186292 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2009 Reference: Arch Bronconeumol. 2009 Jan;45(1):4-11. Epub 2009 Jan 3. Impact factor: 1.624 Publication type: Paper in national publication Authors: Lopez, Lorena, Pare, Carles, Gea, Joaquim, Balcells, Eva, Orozco-Levi, Mauricio, Gayete, Angel, Casan, Pere, Guel, Rosa, Gimenez, Ana, Belda, Jose et al. DOI: 10.1016/j.arbres.2008.03.001 [Phenotypic characterization and course of chronic obstructive pulmonary disease in the PAC-COPD Study: design and methods] PMID: 19186292 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2009 Reference: Arch Bronconeumol. 2009 Jan;45(1):4-11. Epub 2009 Jan 3. Impact factor: Publication type: Paper in national publication Authors: Agusti, Alvar; Anto, J M; Anto, Josep M; Balcells, Eva; Barbera, Joan A; Belda, Jose; Benet, Marta; Casan, Pere; de Batlle, Jordi; Escarrabill, Joan et al. DOI: 10.1016/j.arbres.2008.03.001 [Phenotypic heterogeneity of chronic obstructive pulmonary disease] PMID: 19246148 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2009 Reference: Arch Bronconeumol. 2009 Mar;45(3):129-38. Impact factor: 1.624 Publication type: Review in national publication Authors: Anto, Josep M, Sauleda, Jaume, Garcia-Aymerich, Judith, Agusti, Alvar, Belda, Jose, Farrero, Eva, Ferrer, Antoni, Ferrer, Jaume, Galdiz, Juan B, Gea, Joaquim et al. DOI: 10.1016/j.arbres.2008.10.001 [Phenotypic heterogeneity of chronic obstructive pulmonary disease] PMID: 19246148 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2009 Reference: Arch Bronconeumol. 2009 Mar;45(3):129-38. Impact factor: Publication type: Review in national publication Authors: Agusti, Alvar; Anto, Josep M; Barbera, Joan A; Belda, Jose; Farrero, Eva; Ferrer, Antoni; Ferrer, Jaume; Galdiz, Juan B; Garcia-Aymerich, Judith; Gea, Joaquim et al. DOI: 10.1016/j.arbres.2008.10.001 Pagination First page « First Previous page ‹ Previous … Page 1712 Page 1713 Page 1714 Page 1715 Current page 1716 Page 1717 Page 1718 Page 1719 Page 1720 … Next page Next › Last page Last »
